These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 4865709
1. The quantitative evaluation of intravenous methocarbamol in the relief of spasticity. Levine IM, Jossmann PB, Rudd J, De Angelis V. Neurology; 1968 Jan; 18(1 Pt 1):69-74. PubMed ID: 4865709 [No Abstract] [Full Text] [Related]
2. A controlled study of methocarbamol (Robaxin) in acute painful musculoskeletal conditions. Tisdale SA, Ervin DK. Curr Ther Res Clin Exp; 1975 Jun; 17(6):525-30. PubMed ID: 808374 [No Abstract] [Full Text] [Related]
3. Relief of acute musculoskeletal symptoms with intravenous methocarbamol (robaxin injectable): a placebo-controlled study. Dent RW, Ervin DK. Curr Ther Res Clin Exp; 1976 Nov; 20(5):661-5. PubMed ID: 825351 [No Abstract] [Full Text] [Related]
4. Methocarbamol in the treatment of cerebral palsy in children. Bjerre I, Blennow G. Neuropadiatrie; 1971 Oct; 3(2):140-6. PubMed ID: 4947731 [No Abstract] [Full Text] [Related]
5. A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Glass A, Hannah A. Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209 [No Abstract] [Full Text] [Related]
6. A double-blind trial of methocarbamol versus placebo in painful muscle spasm. Valtonen EJ. Curr Med Res Opin; 1975 Nov; 3(6):382-5. PubMed ID: 1102260 [Abstract] [Full Text] [Related]
7. [Spasm and other painful conditions of skeletal muscles. Clinical investigation of the effectiveness and tolerance of the centrally-acting muscle relaxant methocarbamol]. Fortschr Med Suppl; 1992 Nov; 120():1-7. PubMed ID: 1537584 [No Abstract] [Full Text] [Related]
8. [Methocarbamol in the rehabilitation of spastic paresis in infantile cerebral palsy]. Ignatowicz R, Gdakowicz B, Kowalczyk K, Zukowska-Walczyk E. Wiad Lek; 1974 Sep; 27(17):1546-50. PubMed ID: 4410126 [No Abstract] [Full Text] [Related]
9. Spasticity and the effect of dantrolene sodium. Monster AW. Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132 [No Abstract] [Full Text] [Related]
10. Letter: Treatment of spasticity in multiple sclerosis with dantrolene. Tolosa ES, Soll RW, Loewenson RB. JAMA; 1975 Sep 08; 233(10):1046. PubMed ID: 1099254 [No Abstract] [Full Text] [Related]
12. Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study. Basmajian JV, Yucel V. Am J Phys Med; 1974 Oct 08; 53(5):223-8. PubMed ID: 4153338 [No Abstract] [Full Text] [Related]
13. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)]. Gonsette RE, Capart T, Demonty L. Acta Neurol Belg; 1978 Oct 08; 78(3):141-7. PubMed ID: 352084 [Abstract] [Full Text] [Related]
14. Painful tonic seizure in multiple sclerosis treatment with diphenylhydantoin and carbamazepine. Kuroiwa Y, Shibasaki H. Folia Psychiatr Neurol Jpn; 1968 Oct 08; 22(2):107-19. PubMed ID: 5755134 [No Abstract] [Full Text] [Related]
15. Parafon Forte versus Robaxisal in skeletal muscle disorders: a double-blind study. Gready DM. Curr Ther Res Clin Exp; 1976 Nov 08; 20(5):666-73. PubMed ID: 825352 [No Abstract] [Full Text] [Related]
16. [Clinical effects of Myolastan in cases of diseases involving increased muscle tone]. Kiwerski J, Szurek A. Pol Tyg Lek; 1971 Apr 12; 26(15):560-2. PubMed ID: 5578686 [No Abstract] [Full Text] [Related]